Journal article
Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial
Abstract
BACKGROUND AND PURPOSE: Stereotactic body radiotherapy (SBRT) carries potentially higher risks for ultracentral (UC) NSCLC with limited prospective data to guide decision making. We conducted a secondary analysis from a randomized trial of SBRT and conventionally hypofractionated radiation (CRT) to assess these risks.
MATERIALS AND METHODS: Patients (n = 233) with medically inoperable stage I NSCLC were recruited from 2014 to 2020. Patients …
Authors
Wu CHD; Wierzbicki M; Parpia S; Kundapur V; Bujold A; Filion E; Lau H; Faria S; Ahmed N; Leong N
Journal
Radiotherapy and Oncology, Vol. 202, ,
Publisher
Elsevier
Publication Date
January 2025
DOI
10.1016/j.radonc.2024.110605
ISSN
0167-8140